Sathyen A. Prabhu

1001 Decarie Boulevard
Montreal, QC H4A3J1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma.

Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma.

Journal: The Journal of investigative dermatology

Published: August 28, 2023

Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

Journal: Molecular cancer therapeutics

Published: February 08, 2022

Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance.

Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance.

Journal: Autophagy

Published: June 02, 2021

The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.

The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.

Journal: International journal of molecular sciences

Published: May 11, 2020

MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.

MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.

Journal: Oncogene

Published: June 16, 2019

Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas.

Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 14, 2018

Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib.

Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 11, 2016

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.

Journal: Oncotarget

Published: October 20, 2015

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.

Journal: Oncotarget

Published: May 27, 2015

Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.

Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: December 03, 2013

Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression.

Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression.

Journal: Cancer epidemiology

Published: May 02, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026